We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Your guide to a disrupted world
Add this topic to your myFT Digest for news straight to your inbox
Severin Schwan will be succeeded by Thomas Schinecker, head of drugmaker’s diagnostics unit
Further blow to UK stock market comes despite government’s efforts to promote life sciences
Help us find Britain’s healthiest workplace
There is a growing awareness of the importance of sleep after the pandemic disrupted working lives and rest patterns
Pharmaceutical group issues downbeat forecast despite better than expected quarterly results
The latest strains have spread fast and governments are trying to catch up
The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain
Member states, BioNTech/Pfizer edge closer to deal to delay jab deliveries amid oversupply and rising case numbers
Just one drug remains effective for the sexually transmitted disease but soon the bacteria may be able to evade it
Infected wounds are growing cause for concern in the Middle East, Ukraine and beyond
Investors cool on biggest London listing since Glencore in 2011 on worries about inflation and consumer confidence
Oxford Science Enterprises wants to step up funding of companies derived from academic research
Emma Walmsley believes listing of consumer health business will strengthen pharma division
Tracking of more than 7mn records across 68 countries using wristbands confirms ‘insufficient’ rest due to unusual heat
US president voices support for drug pricing measures after Manchin balks at climate and clean energy provisions
ONS publishes data showing percentage of people testing positive for coronavirus still rising
WHO and Unicef warn of fall in immunisations for diseases such as diphtheria, polio and measles
Novo Nordisk’s Wegovy uses a hormone to regulate hunger. It’s wildly effective, but is it misguided?
Experts attribute shortfall to small size of British market now it is regulated separately and complexity of dealing with NHS
Ruling allows European probe of Illumina’s $8bn Grail takeover and sets precedent for deeper oversight of deals
Intensifying medical needs of baby boomers have exposed flaws in health system
Antiviral treatment Paxlovid is being widely prescribed despite questions about its effectiveness
Infections less likely to cause severe illness or death than past waves, FT analysis suggests
Shots unused due to factors including hesitancy, improper storage and donations delivered close to expiry dates
Research shows denying access worsens inequality and creates financial hardships for women and their families
International Edition
